SI-BONE Quarterly Income Statement
NASDAQ: SIBNHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
SI-BONE revenue and earnings
In the quarter ended Jun 30, 2026, SI-BONE generated $56.0 million in revenue, up 15.2% from the same quarter a year earlier. SI-BONE reported a net loss of $4.1 million, compared with a loss of $6.2 million a year earlier. Gross margin was 79.5% (down from 79.8%) and operating margin -8.6%.
Diluted earnings per share came in at -$0.09.
Summary generated from market data by MetaCap's automated system. Methodology
SI-BONE income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 56.01M | 52.59M | 56.35M | 48.66M | 48.63M | 47.29M | 49.00M | 40.34M | 39.97M | 37.87M | 38.86M | 34.01M |
| Revenue growth (YoY) | +15.18% | +11.20% | +14.99% | +20.61% | +21.67% | +24.88% | +26.10% | +18.60% | +20.01% | +15.77% | +21.61% | +28.68% |
| Cost of Revenue | 11.46M | 10.64M | 11.82M | 9.81M | 9.82M | 9.60M | 10.22M | 8.44M | 8.39M | 8.00M | 10.18M | 7.04M |
| Gross Profit | 44.55M | 41.94M | 44.53M | 38.85M | 38.81M | 37.70M | 38.78M | 31.90M | 31.58M | 29.86M | 28.68M | 26.97M |
| Operating Expenses | 49.35M | 47.04M | 46.99M | 44.23M | 45.81M | 45.17M | 44.27M | 39.54M | 41.65M | 41.91M | 41.18M | 38.14M |
| Research & Development | 5.22M | 4.19M | 4.36M | 4.24M | 4.31M | 4.53M | 3.87M | 3.99M | 4.35M | 4.34M | 4.16M | 3.92M |
| Selling, General & Admin | 44.13M | 42.84M | 42.63M | 39.99M | 41.50M | 40.64M | 40.40M | 35.54M | 37.30M | 37.56M | 37.02M | 34.22M |
| Operating Income | -4.81M | -5.09M | -2.46M | -5.38M | -7.00M | -7.48M | -5.49M | -7.63M | -10.08M | -12.04M | -12.51M | -11.17M |
| Interest Expense | 598.00K | 592.00K | 630.00K | 670.00K | 666.00K | 662.00K | 793.00K | 884.00K | 880.00K | 881.00K | 889.00K | 884.00K |
| Other Income (Expense) | -16.00K | 1.00K | 2.00K | -28.00K | -2.00K | 8.00K | 8.00K | 6.00K | 4.00K | -93.00K | 185.00K | -143.00K |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -4.09M | -4.33M | -1.64M | -4.57M | -6.15M | -6.54M | -4.50M | -6.58M | -8.94M | -10.90M | -10.98M | -10.02M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -0.09 | -0.10 | -0.04 | -0.11 | -0.14 | -0.15 | -0.10 | -0.16 | -0.22 | -0.27 | -0.26 | -0.25 |
| EPS (Diluted) | -0.09 | -0.10 | -0.04 | -0.11 | -0.14 | -0.15 | -0.10 | -0.16 | -0.22 | -0.27 | -0.26 | -0.25 |
| Shares Outstanding (Basic) | 44.48M | 43.96M | — | 43.19M | 42.79M | 42.34M | — | 41.72M | 41.32M | 40.93M | — | 40.27M |
| Shares Outstanding (Diluted) | 44.48M | 43.96M | — | 43.19M | 42.79M | 42.34M | — | 41.72M | 41.32M | 40.93M | — | 40.27M |
| EBITDA | -3.13M | -3.48M | -825.00K | -3.90M | -5.64M | -6.20M | -4.28M | -6.55M | -9.09M | -10.95M | -10.93M | -9.64M |
| Gross Margin | 79.54% | 79.76% | 79.03% | 79.84% | 79.80% | 79.71% | 79.13% | 79.09% | 79.00% | 78.87% | 73.80% | 79.30% |
| Operating Margin | -8.58% | -9.68% | -4.37% | -11.06% | -14.40% | -15.82% | -11.21% | -18.92% | -25.21% | -31.80% | -32.18% | -32.84% |
| Net Margin | -7.30% | -8.24% | -2.92% | -9.38% | -12.65% | -13.83% | -9.17% | -16.30% | -22.36% | -28.80% | -28.26% | -29.46% |
This table shows 12 quarterly periods of SI-BONE's income statement, from Q2 2026 back to Q3 2023, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow SIBN's reporting calendar. What is a income statement?